{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:21:13Z","timestamp":1777998073363,"version":"3.51.4"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The incidence of coagulopathy, which was responsible for poor outcomes, was commonly seen among patients with sepsis. In the current study, we aim to determine whether the presence of sepsis-associated coagulopathy (SAC) predicts the clinical outcomes among critically ill patients with postoperative sepsis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a single-center retrospective cohort study by including patients with sepsis admitted to surgical ICU of Chinese PLA General Hospital from January 1, 2014 to December 31, 2018. Baseline characteristics and clinical outcomes were compared with respect to the presence of SAC. Kaplan-Meier analysis was applied to calculate survival rate, and Log-rank test was carried out to compare the differences between two groups. Furthermore, multivariable Cox and logistic and linear regression analysis were performed to assess the relationship between SAC and clinical outcomes, including hospital mortality, development of septic shock, and length of hospital stay (LOS), respectively. Additionally, both sensitivity and subgroup analyses were performed to further testify the robustness of our findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 175 patients were included in the current study. Among all included patients, 41.1% (72\/175) ICU patients were identified as having SAC. In-hospital mortality rates were significantly higher in the SAC group when compared to that of the No SAC group (37.5% vs. 11.7%; <jats:italic>p<\/jats:italic> &amp;lt; 0.001). By performing univariable and multivariable regression analyses, presence of SAC was demonstrated to significantly correlate with an increased in-hospital mortality for patients with sepsis in surgical ICU [Hazard ratio (HR), 3.75; 95% Confidence interval (CI), 1.90\u20137.40; <jats:italic>p<\/jats:italic> &amp;lt; 0.001]. Meanwhile, a complication of SAC was found to be the independent predictor of the development of septic shock [Odds ratio (OR), 4.11; 95% CI, 1.81\u20139.32; <jats:italic>p<\/jats:italic> = 0.001], whereas it was not significantly associated with prolonged hospital LOS (OR, 0.97; 95% CI, 0.83\u20131.14; <jats:italic>p<\/jats:italic> = 0.743).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The presence of SAC was significantly associated with increased risk of in-hospital death and septic shock among postoperative patients with sepsis admitted to ICU. Moreover, there was no statistical difference of hospital LOS between the SAC and no SAC groups.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.783234","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T05:51:07Z","timestamp":1644904267000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Sepsis-Associated Coagulopathy Predicts Hospital Mortality in Critically Ill Patients With Postoperative Sepsis"],"prefix":"10.3389","volume":"9","author":[{"given":"Chao","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-meng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-ping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren-qi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-hui","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet (London, England)."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet (London, England)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/MCC.0b013e328348bee2","article-title":"Postoperative sepsis","volume":"17","author":"Fried","year":"2011","journal-title":"Curr Opin Crit Care."},{"key":"B6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/SHK.0000000000000854","article-title":"Is coagulopathy an appropriate therapeutic target during critical illness such as trauma or sepsis?","volume":"48","author":"Moore","year":"2017","journal-title":"Shock (Augusta, Ga)."},{"key":"B7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/CCM.0000000000002997","article-title":"Sepsis-associated coagulopathy severity predicts hospital mortality","volume":"46","author":"Lyons","year":"2018","journal-title":"Crit Care Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","article-title":"Coagulation and sepsis","volume":"149","author":"Levi","year":"2017","journal-title":"Thromb Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ajcp\/aqw195","article-title":"Disseminated intravascular coagulation","volume":"146","author":"Boral","year":"2016","journal-title":"Am J Clin Pathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1111\/anae.14344","article-title":"Implications of deranged activated partial thromboplastin time for anaesthesia and surgery","volume":"73","author":"Loizou","year":"2018","journal-title":"Anaesthesia."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.mcna.2013.07.004","article-title":"Patients with disorders of thrombosis and hemostasis","volume":"97","author":"Orfanakis","year":"2013","journal-title":"Med Clin North Am."},{"key":"B12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ccc.2016.08.003","article-title":"Coagulopathy of trauma","volume":"33","author":"Cohen","year":"2017","journal-title":"Crit Care Clin."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.jpedsurg.2015.08.007","article-title":"Rotational thromboelastometry in the diagnosis of coagulopathy in major pediatric surgical operations","volume":"50","author":"Sangkhathat","year":"2015","journal-title":"J Pediatr Surg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1055\/s-0040-1718736","article-title":"Evaluation of sepsis-induced coagulopathy in critically ill pediatric patients with septic shock","volume":"121","author":"Jhang","year":"2021","journal-title":"Thromb Haemost."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1097\/ALN.0000000000003122","article-title":"Sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"132","author":"Iba","year":"2020","journal-title":"Anesthesiology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/jcm8050728","article-title":"Advance in the management of sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"8","author":"Iba","year":"2019","journal-title":"J Clin Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/MCC.0000000000000109","article-title":"Coagulation and transfusion in the postoperative bleeding patient","volume":"20","author":"Kozek-Langenecker","year":"2014","journal-title":"Curr Opin Crit Care."},{"key":"B19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/TA.0000000000000134","article-title":"Thrombelastography and rotational thromboelastometry early amplitudes in 182 trauma patients with clinical suspicion of severe injury","volume":"76","author":"Meyer","year":"2014","journal-title":"J Trauma Acute Care Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4161\/viru.26482","article-title":"Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock","volume":"5","author":"De Backer","year":"2014","journal-title":"Virulence."},{"key":"B22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3389\/fmed.2020.00445","article-title":"A Machine Learning-Based Prediction of Hospital Mortality in Patients With Postoperative Sepsis","volume":"7","author":"Yao","year":"2020","journal-title":"Frontiers in medicine."},{"key":"B23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/ACO.0000000000000051","article-title":"Viscoelastic guidance of resuscitation","volume":"27","author":"Stensballe","year":"2014","journal-title":"Curr Opin Anaesthesiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"Cd007871","DOI":"10.1002\/14651858.CD007871.pub3","article-title":"Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding","volume":"2016","author":"Wikkels\u00f8","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13054-019-2573-8","article-title":"Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS)-a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy","volume":"23","author":"Berthelsen","year":"2019","journal-title":"Critical care (London, England)."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","article-title":"A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation","volume":"41","author":"Vincent","year":"2013","journal-title":"Crit Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/jth.13230","article-title":"Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials","volume":"14","author":"Umemura","year":"2016","journal-title":"J Thromb Haemost."},{"key":"B28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jth.12841","article-title":"Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis","volume":"13","author":"Yamakawa","year":"2015","journal-title":"J Thromb Haemost."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.783234\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T05:51:10Z","timestamp":1644904270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.783234\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":28,"alternative-id":["10.3389\/fmed.2022.783234"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.783234","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]},"article-number":"783234"}}